Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

GKB OPHTHALMICS LTD. - 533212 - Intimation Under Regulation 30 Of SEBI ( Listing Obligations And Disclosure Requirements) Regulations, 2015 -Appointment Of Independent Director, Cessation Of Independent Director And Re-Constitution Of Committees Of The Board.

 In compliance with the provisions of Regulation 30 read with Schedule III of SEBI ( Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors have passed circular resolutions today, i.e. May 22, 2024 with respect to 1. Appointment of Mrs. Sandhya Ajit Kamat as an Additional Director ( Independent & Non Executive), with effect from May 22, 2024. 2. Retirement of Mr. Anil Palekar , as Independent Non Executive Director of the Company with effect from close of business hours on May 22, 2024, due to completion of his tenure. 3. Reconstitution of the Committees of the Board of Directors. We request you to kindly take note of the same.
22-05-2024
Bigul

GKB OPHTHALMICS LTD. - 533212 - Board Meeting Intimation for Approval Of Audited Standalone And Consolidated Financial Results For The Quarter And Year Ended March 31, 2024.

 GKB OPHTHALMICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 ,inter alia, to consider and approve the audited standalone and consolidated financial results for the quarter and year ended March 31, 2024. The notice can be accessed at the Company''s website at www.gkb.net Further, notice is hereby given with reference to the above meeting of the Board of Directors that the trading window for dealing with equity shares of the company, by designated persons, under SEBI (Prohibition of Insider Trading) Regulation, 2015, had been closed from April 01, 2024 , will now re-open on Monday,June 03, 2024.
25-04-2024
Bigul

GKB OPHTHALMICS LTD. - 533212 - Compliance Certificate Under Regulation 40(9)& 40(10) Of SEBI (Listing Obligations And Disclosure Requirements) Regulation ,2015 For The Year Ended March 31, 2024.

 Pursuant to Regulation 40(10) of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, please find enclosed and Compliance Certificate, issued by Practicing Company Secretary, for the year ended March 31, 2024. Please acknowledge receipt.
18-04-2024
Bigul

GKB OPHTHALMICS LTD. - 533212 - Non Applicability Of Circular No. SEBI/HO/DDHS/CIR/P/2018/144, Dated November 26, 2018.

 Pursuant to Circular no. SEBI/HO/DDHS/CIR/P/2018/144,dated November 26, 2018, issued by the Securities and Exchange Board of India, we hereby confirm that GKB Ophthalmics Limited, is not a "Large Corporate", as defined in the said Circular and hence , the said Circular is not applicable to us. Kindly take the above information on record.
11-04-2024
Bigul

GKB OPHTHALMICS LTD. - 533212 - Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosures Requirements) Regulation, 2015, For The Year Ended March 31, 2024.

 Please find herewith the Compliance Certificate under Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the financial year ended March 31, 2024.
08-04-2024
Bigul

GKB OPHTHALMICS LTD. - 533212 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Please find herewith Certificate under Regulation 74(5) of SEBI(Depositories and Participants) Regulations, 2018, for the quarter ended March 31, 2024. Kindly acknowledge receipt of the same.
08-04-2024
Bigul

GKB OPHTHALMICS LTD. - 533212 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015

 Pursuant to provision of Regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulation ,2015, intimation be and is hereby given that Mr. K.G. Gupta, Promoter ,Director of the Company , has purchased 1900 equity shares aggregating to Rs. 1,67,699.24/- on 27.03.2024 of the Company, on market. Copy of disclosure required under Regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulation,2015, is enclosed herewith. Copy of disclosure received from Mr. K.G.Gupta is also enclosed herewith. Please acknowledge and take the same on record.
30-03-2024
Bigul

GKB OPHTHALMICS LTD. - 533212 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015

 Pursuant to provision of Regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulation ,2015, intimation be and is hereby given that Mr. K.G. Gupta, Promoter ,Director of the Company , has purchased 1900 equity shares aggregating to Rs. 1,67,699.24/- on 27.03.2024 of the Company, on market. Copy of disclosure required under Regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulation,2015, is enclosed herewith. Copy of disclosure received from Mr. K.G.Gupta is also enclosed herewith. Please acknowledge and take the same on record.
30-03-2024
Bigul

GKB OPHTHALMICS LTD. - 533212 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015

 Pursuant to provision of Regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulation, 2015 (PIT Regulation, 2015), intimation be and is hereby given that Krishna Gopal Gupta & Sons (HUF), has purchased 1397 equity shares aggregating to Rs. 1,23,838.14 /- from 19.02.2024 to 28.03.2024, on market ,which is not exceeding the threshold limit as prescribed under Regulation 7(2) of PIT Regulation, 2015. However, as a good Corporate Governance measure, the disclosure required under Regulation 7(2) read with Regulation 6(2) of PIT Regulation ,2015,is enclosed herewith along with the copy of disclosure received from Krishna Gopal Gupta and Sons-HUF. Please acknowledge and take the same on record.
30-03-2024
Bigul

GKB OPHTHALMICS LTD. - 533212 - Closure of Trading Window

 Pursuant to SEBI (Prohibition of Insider Trading) Regulation 2015, as amended from time to time, the "Trading Window" for dealing /trading in the shares of the Company shall remain closed from April 01, 2024, till the completion of 48 hours after the declaration of the financial results of the Company, for the quarter and financial year ended March 31, 2024. Enclosed please find the disclosure. Kindly take the information on record.
26-03-2024
Next Page
Close

Let's Open Free Demat Account